Royal Bank Of Canada Oncolytics Biotech Inc Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 74,546 shares of ONCY stock, worth $63,364. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,546

Previous 62,267 19.72%

Holding current value

$63,364

Previous $61,000 4.92%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.87 - $1.08 $10,682 - $13,261	12,279 Added 19.72%	74,546 $64,000
Q2 2024 Aug 14, 2024	BUY	$0.99 - $1.24 $1,221 - $1,530	1,234 Added 2.02%	62,267 $61,000
Q1 2024 Nov 05, 2024	SELL	$0.89 - $1.36 $1,098 - $1,678	-1,234 Reduced 1.98%	61,033 $64,000
Q1 2024 May 15, 2024	BUY	$0.89 - $1.36 $5,436 - $8,306	6,108 Added 11.12%	61,033 $64,000
Q4 2023 Feb 14, 2024	SELL	$1.22 - $2.09 $980 - $1,680	-804 Reduced 1.44%	54,925 $74,000
Q3 2023 Nov 14, 2023	BUY	$1.98 - $3.24 $4,997 - $8,177	2,524 Added 4.74%	55,729 $121,000
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.74 $500 - $1,235	-451 Reduced 0.84%	53,205 $138,000
Q1 2023 May 15, 2023	BUY	$1.2 - $1.91 $8,666 - $13,794	7,222 Added 15.55%	53,656 $64,000
Q4 2022 Feb 14, 2023	SELL	$1.17 - $2.12 $2,815 - $5,100	-2,406 Reduced 4.93%	46,434 $75,000
Q3 2022 Nov 14, 2022	BUY	$0.98 - $1.51 $5,049 - $7,781	5,153 Added 11.8%	48,840 $60,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.59 $1,155 - $2,160	-1,359 Reduced 3.02%	43,687 $44,000
Q1 2022 May 16, 2022	BUY	$1.31 - $2.02 $4,676 - $7,211	3,570 Added 8.61%	45,046 $71,000
Q4 2021 Feb 14, 2022	BUY	$1.39 - $2.3 $1,280 - $2,118	921 Added 2.27%	41,476 $58,000
Q3 2021 Nov 15, 2021	BUY	$1.93 - $2.77 $7,532 - $10,811	3,903 Added 10.65%	40,555 $85,000
Q2 2021 Aug 16, 2021	BUY	$2.6 - $4.64 $95,295 - $170,065	36,652 New	36,652 $102,000

Others Institutions Holding ONCY

# of Institutions

Shares Held

1.18M

Call Options Held

Put Options Held

View Full List

About ONCOLYTICS BIOTECH INC

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

More about ONCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Oncolytics Biotech Inc Transaction History